Clinical Protocol Office
Extraordinary Research. Exceptional Care.
Carrie Lee, MD, MPH, Medical Director
Jared Weiss, MD, Associate Medical Director, Finance
Stefanie Belanger, CCRP, Assistant Director, Clinical Research Operations
Jessica Huamani-Bundy, MS, CCRC, Assistant Director, Multicenter Clinical Trials Operations
Brian Kiley, MBA, Assistant Director, Finance
Stephanie Ladd, CCRP, Assistant Director, Clinical Research & Network Operations
LaNita Martin, BSM, MSHS, Assistant Director, Regulatory and Compliance
Mary O’Dwyer, MRP, CCRP, Assistant Director, Data Operations & Clinical Trials System
The Clinical Protocol Office (CPO) and its approximately 130 healthcare professionals support the design and conduct of oncology clinical trials. The CPO is responsible for patient and study coordination-related activities, including subject evaluation and registration, toxicity assessment and safety monitoring of novel therapeutics and patient education. The CPO assists and facilitates protocol development, contract acquisition and management, regulatory oversight and compliance, preparation and submission of INDs for novel studies and novel compounds, internal and external study audits, quality control, and data acquisition, transcription and management. The CPO works with the Data Safety Monitoring Committee (DSMC), Compliance Committee and the Protocol Review Committee (PRC) to assure patient eligibility and safety, regulatory compliance and quality, reproducible data.Find a Clinical Trial
Third floor, UNC Lineberger Comprehensive Cancer Center
Monday – Friday, 8:30 a.m. – 5 p.m.
For More Information
For questions regarding the Protocol Review Committee (PRC), contact Stacy Maxwell, email@example.com or 919-962-8566. For questions regarding the Data and Safety Monitoring Committee (DSMC) or the Compliance Committee, contact Beth Sappelt, firstname.lastname@example.org or 919-843-8625.